INDICATION
DOVATO is indicated as a complete regimen to treat HIV-1 infection in adults with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known resistance to any component of DOVATO.

Register to Talk
to the Experts

Read more »

DISCOVER DOVATO

TANGO Trial

See trial results for a switch to DOVATO in appropriate virologically suppressed adults

Read more »

GEMINI 1 & 2 Trials

See trial results and 96-week long-term data

Read more »

Risks & Side Effects

Info about the possible risks and side effects, including drug-related adverse events and rates of discontinuation

Read more »

Hear Real Patient Stories

A DEEPER LOOK AT DOVATO

Request a Rep

Request a visit from a ViiV Healthcare representative in your area

Read more »

Email Updates

Sign up to get the latest updates on DOVATO

Read more »

ViiV Medical Information

View our medical information library if you have a question about DOVATO

Read more »

DLLWCNT200019